Progyny (NASDAQ: PGNY), is a advantages administration firm that focuses on fertility and household
Progyny (NASDAQ: PGNY), is a advantages administration firm that focuses on fertility and household constructing advantages options. The corporate’s inventory is up 90% since its itemizing in late October, presently buying and selling at over $30 per share. The IPO was priced at $13. The rally is pushed by robust demand for the inventory, provided that fertility protection is increasing amongst employers. Furthermore, the corporate has been recording sturdy income progress (over 110% CAGR over the past 2 years) and is predicted to publish an working revenue this yr. Nevertheless, it’s attainable that the corporate may face some promoting strain subsequent yr, as its IPO lock-up expires in April 2020.
We ‘step again’ from these current swings to overview Progyny’s efficiency over the previous few years, as a context for what would possibly come subsequent. Our Interactive dashboard, Why Progeny Stock Is Up 90% Since Its IPO critiques the close to time period causes and the large image.
The context for the previous few years:
A more in-depth look At Progyny’s Complete Revenues over the previous few years and the outlook
…